On April 14, 2025, Soligenix, Inc. (NASDAQ:SNGX) announced interim data from the ongoing, open label, investigator-initiated study (IIS) of HyBryteâ„¢ (synthetic hypericin) treatment for up to 54 weeks ...
Trustwave’s SpiderLabs researchers have found a piece of malware that collects data entered into Web-based forms, pretending to be a module for Microsoft’s Internet Information Services (IIS) ...